Senores Pharma.

{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "966.55",
    "chg": 34.1,
    "chgp": "3.66%",
    "dir": 1,
    "prev_price": "932.45",
    "mcapval": "4,348.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544319",
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0RB801010",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "3.87 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Gains 8.28%: 4 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-828-4-key-factors-driving-the-weeks-rally-3982612",
        "imagepath": "",
        "date": "2026-05-09 09:04:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 5:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>May 8:</strong> New 52-week high of Rs.959</p>\n                    <p><strong>May 8:</strong> All-time high reached at Rs.957.70</p>\n                    <p><strong>May 8:</strong> Multibagger returns highlighted amid robust growth and institutional interest</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.892.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.966.55</div><div cl..."
      },
      {
        "title": "102% Stock Return, 20% Profit Growth: What's Driving Senores Pharmaceuticals Ltd's Multibagger Rerating?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-delivers-multibagger-returns-amid-robust-growth-and-institutional-interest-3981811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_multibagger_3981811.png",
        "date": "2026-05-08 13:35:03",
        "description": "A 102.36% stock return in one year. An 11.49% growth in net profit over the same period. The gap between those two numbers — roughly 90 percentage points — is driven largely by the market's willingness to pay a higher multiple for each rupee of Senores Pharmaceuticals Ltd's earnings. That divergence is the key to understanding the recent rerating."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 959",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-of-rs959-3981677",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3981677.png",
        "date": "2026-05-08 11:10:25",
        "description": "With a near doubling in price from Rs 474 to Rs 959 over the past year, Senores Pharmaceuticals Ltd has surged to a fresh 52-week high on 8 May 2026, propelled by a confluence of robust technical indicators and sustained price momentum."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 957.70 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3981622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3981622.png",
        "date": "2026-05-08 10:42:25",
        "description": "Extending its winning streak to four sessions, Senores Pharmaceuticals Ltd surged 2.71% on 8 May 2026 to close at a fresh all-time high of Rs 957.70, just 0.81% above its previous 52-week peak. This rally comes amid broad outperformance against the Sensex, which declined 0.43% on the same day, underscoring the stock’s robust momentum across multiple timeframes."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3975095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_technicaldot_3975095.png",
        "date": "2026-05-05 08:08:57",
        "description": "Senores Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, and moving averages reveal a complex interplay of bullish and bearish signals, reflecting cautious optimism among investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Senores Pharmaceuticals Gains 0.93%: 4 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-093-4-key-factors-driving-the-week-3971351",
        "imagepath": "",
        "date": "2026-05-02 09:02:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> New 52-week and all-time high at Rs.945.95</p>\n                    <p><strong>28 Apr:</strong> Fresh all-time high of Rs.950 reached</p>\n                    <p><strong>29 Apr:</strong> Price correction with increased selling pressure</p>\n                    <p><strong>30 Apr:</strong> Consolidation near weekly close at Rs.898.70</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.890.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.898.70</div><div class=\"stat-change..."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-buy-3972229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_mojoScore_3972229.png",
        "date": "2026-05-01 10:10:04",
        "description": "Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 950",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs950-3966155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_priceRelatedfactors_3966155.png",
        "date": "2026-04-28 09:48:53",
        "description": "With a remarkable 80.78% gain over the past year, Senores Pharmaceuticals Ltd surged to a fresh 52-week and all-time high of Rs 950 on 28 Apr 2026, showcasing a powerful momentum that has outpaced the broader market by a wide margin."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 950 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-at-rs950-3966081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_priceRelatedfactors_3966081.png",
        "date": "2026-04-28 09:37:14",
        "description": "Extending its impressive rally, Senores Pharmaceuticals Ltd touched a fresh all-time high of Rs 950 on 28 Apr 2026, marking a significant milestone in its market journey amid broad sector strength."
      }
    ],
    "total": 216,
    "sid": "10039497",
    "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "29-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Senores Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24290GJ2017PLC100263</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>54.07</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Vinay Kumar Mishra <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@senorespharma.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Deval Rajnikant Shah <br/> Designation: Chief Financial Officer and Whole Time Director <br/> EmailId: dshah@senorespharma.com</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Apr-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of SEBI (DP)Regulations2018 for quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "03-Apr-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharmaceuticals Gains 8.28%: 4 Key Factors Driving the Week’s Rally

2026-05-09 09:04:00

Key Events This Week

May 5: Technical momentum shifts amid mixed indicator signals

May 8: New 52-week high of Rs.959

May 8: All-time high reached at Rs.957.70

May 8: Multibagger returns highlighted amid robust growth and institutional interest

Week Open

Rs.892.65

Week Close

Rs.966.55

Read full news article

102% Stock Return, 20% Profit Growth: What's Driving Senores Pharmaceuticals Ltd's Multibagger Rerating?

2026-05-08 13:35:03

A 102.36% stock return in one year. An 11.49% growth in net profit over the same period. The gap between those two numbers — roughly 90 percentage points — is driven largely by the market's willingness to pay a higher multiple for each rupee of Senores Pharmaceuticals Ltd's earnings. That divergence is the key to understanding the recent rerating.

Read full news article

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 959

2026-05-08 11:10:25

With a near doubling in price from Rs 474 to Rs 959 over the past year, Senores Pharmaceuticals Ltd has surged to a fresh 52-week high on 8 May 2026, propelled by a confluence of robust technical indicators and sustained price momentum.

Read full news article

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 957.70 as Momentum Builds Across Timeframes

2026-05-08 10:42:25

Extending its winning streak to four sessions, Senores Pharmaceuticals Ltd surged 2.71% on 8 May 2026 to close at a fresh all-time high of Rs 957.70, just 0.81% above its previous 52-week peak. This rally comes amid broad outperformance against the Sensex, which declined 0.43% on the same day, underscoring the stock’s robust momentum across multiple timeframes.

Read full news article

Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:08:57

Senores Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, and moving averages reveal a complex interplay of bullish and bearish signals, reflecting cautious optimism among investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Senores Pharmaceuticals Gains 0.93%: 4 Key Factors Driving the Week

2026-05-02 09:02:46

Key Events This Week

27 Apr: New 52-week and all-time high at Rs.945.95

28 Apr: Fresh all-time high of Rs.950 reached

29 Apr: Price correction with increased selling pressure

30 Apr: Consolidation near weekly close at Rs.898.70

Week Open

Rs.890.40

Week Close

Rs.898.70

Read full news article

Senores Pharmaceuticals Ltd is Rated Buy

2026-05-01 10:10:04

Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 950

2026-04-28 09:48:53

With a remarkable 80.78% gain over the past year, Senores Pharmaceuticals Ltd surged to a fresh 52-week and all-time high of Rs 950 on 28 Apr 2026, showcasing a powerful momentum that has outpaced the broader market by a wide margin.

Read full news article

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 950 as Momentum Builds Across Timeframes

2026-04-28 09:37:14

Extending its impressive rally, Senores Pharmaceuticals Ltd touched a fresh all-time high of Rs 950 on 28 Apr 2026, marking a significant milestone in its market journey amid broad sector strength.

Read full news article

View All News